8 High Growth UK Stocks to Invest In

4. Clarivate (NYSE:CLVT)  

5-Year Revenue CAGR: 21.96%  

No of Hedge Funds: 27

Clarivate (NYSE:CLVT) is a leading global provider of information and analytics services, serving the research and intellectual property sectors. The company was formed in 2016 from the merger of Thomson Reuters’ Intellectual Property & Science and Financial & Risk businesses.

On September 23, Clarivate (NYSE:CLVT) announced a strategic partnership with Relatable Healthcare to launch a Product Relationship Management (PRM) platform for MedTech companies. This platform integrates the company’s competitive intelligence with Relatable’s software to offer a centralized source of product information, enhancing revenue growth and efficiency for MedTech manufacturers and distributors by providing access to detailed product data, cross-references, inventory, and sales materials.

Clarivate (NYSE:CLVT) emphasizes subscription-based services, which provide consistent revenue streams and strengthen its position in the data-driven services industry. In Q2, the company’s Academic and Government (A&G) segment demonstrated solid organic growth, with subscription revenues rising by over 3% and a renewal rate exceeding 96%. The Intellectual Property segment also showed improvement, with organic growth increasing by 270 basis points, indicating stabilization in trademark search volumes.

Clarivate (NYSE:CLVT) is trading 9.15 times its forward-year earnings, which represents a 55.47% discount to the sector median of 20.55. Industry analysts are bullish on the company’s stock price and have a consensus Buy rating at a target price of $7.61, which implies a 12.12% increase from its current level.